Arno Andrew 4

What Happened

• Arno Andrew, a director of Catheter Precision, received a grant of 40,000 derivative securities (reported as an award) on 2026-03-26. The filing lists a reported price of $0.00 and classifies the transaction as a derivative acquisition (award of options). This is a grant/award (not a purchase or sale).

Key Details

• Transaction date: 2026-03-26; Filing date: 2026-03-30 (File appears to meet the SEC two-business-day Form 4 deadline).
• Amount granted: 40,000 derivative shares/options; Reported dollar amount: $0.00.
• Vesting: Footnote states options vest 100% on the 180-day anniversary of the grant date.
• Shares owned after transaction: Not specified in the provided summary of the filing.
• Other notes: Transaction reported as an award (code A); no sale or exercise occurred.

Context

• This was a grant of stock options (a derivative award) rather than an open‑market buy or sale. Grants are common for directors as compensation and do not by themselves indicate immediate buying/selling sentiment. The options vest fully after 180 days and were not exercised or sold at filing.